Nalmefene implant for the long-term treatment of opioid use disorder
Ended Cooperative Agreement Awarded Last action
- Award ID
- UG3DA047707
- Recipient
-
Titan Pharmaceuticals Inc. UEI E6BMASC5QBS9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,678,671
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$62,921 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $6,075,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $2,666,592 |
Show all 19
Quick answers
Who received award UG3DA047707?
UG3DA047707 was awarded to Titan Pharmaceuticals Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2018.
How much is award UG3DA047707 worth?
$8,678,671 has been obligated on UG3DA047707.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award